Decreased regulatory T-cells and CD4+/CD8+ ratio correlate with disease onset and progression in patients with generalized vitiligo

Pigment Cell and Melanoma Research

Volumn 26, Issue 4, 2013, Pages 586-591

  Dwivedi, Mitesh ^a   Laddha, Naresh C ^a   Arora, Prateek ^a   Marfatia, Yogesh S ^a   Begum, Rasheedunnisa ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

Autoimmunity; CD4+ CD8+ ratio; CD4+CD25hiFoxP3+ regulatory T cells (Tregs); FoxP3 expression; Generalized vitiligo; Melanocyte

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; CD4 CD8 RATIO; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENERALIZED VITILIGO; HUMAN; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; RANDOMIZED CONTROLLED TRIAL; REGULATORY T LYMPHOCYTE; VITILIGO;

ADULT; AGED; AGED, 80 AND OVER; AUTOIMMUNITY; CD4-CD8 RATIO; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; MELANOCYTES; MIDDLE AGED; PIGMENTATION; T-LYMPHOCYTES, REGULATORY; VITILIGO; YOUNG ADULT;

EID: 84879781065     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/pcmr.12105     Document Type: Article

References (31)

1. Abdallah, M., and Saad, A. (2009). Evaluation of circulating CD4 + CD25high FoxP3 + T lymphocytes in active non-segmental vitiligo. J. Pan-Arab League Dermatol. 20, 117-125.
2. Afshan, G., Afzal, N., and Qureshi, S. (2012). CD4 + CD25(hi) regulatory T cells in healthy males and females mediate gender difference in the prevalence of autoimmune diseases. Clin. Lab. 58, 567-571.
3. Alkhateeb, A., Fain, P.R., Thody, A., Bennett, D.C., and Spritz, R.A. (2003). Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res. 16, 208-214.
4. Ben Ahmed, M., Zaraa, I., Rekik, R. et al. (2011). Functional defects of peripheral regulatory T lymphocytes in patients with progressive vitiligo. Pigment Cell Melanoma Res. 25, 99-109.
5. Birlea, S.A., Ahmad, F.J., Uddin, R.M. et al. (2013). Association of generalized vitiligo with HLA class II loci in patients from the Indian subcontinent. J. Invest. Dermatol. 133, 1369-1372.
6. Dejaco, C., Duftner, C., Grubeck-Loebenstein, B., and Schermer, M. (2006). Imbalance of regulatory T cells in human autoimmune diseases. Immunology 117, 289-300.
7. Dinesh, R., Hahn, B., and Singh, R. (2011). Sex hormones and gender influence the expression of Foxp3 and regulatory T cells in SLE patients. J. Immunol. 186, 115-118.
8. Dwivedi, M., Laddha, N.C., Imran, M., Shah, B.J., and Begum, R. (2011). Cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) in isolated vitiligo: a genotype-phenotype correlation. Pigment Cell Melanoma Res. 24, 737-740.
9. Dwivedi, M., Laddha, N.C., Shah, K., Shah, B.J., and Begum, R. (2013). Involvement of interferon-gamma (IFNG) genetic variants and intercellular adhesion molecule-1 (ICAM1) in disease onset and progression of generalized vitiligo. J. Interferon Cytokine Res. (In Press).
10. Grimes, P.E., Ghoneum, M., Stockton, T., Payne, C., Kelly, A.P., and Alfred, L. (1986). T cell profiles in vitiligo. J. Am. Acad. Dermatol. 14, 196-201.
11. Halder, R.M., Walters, C.S., Johnson, B.A., Chakrabarti, S.G., and Kenney, J.A. Jr (1986). Aberrations in T lymphocytes and natural killer cells in vitiligo: a flow cytometric study. J. Am. Acad. Dermatol. 14, 733-737.
12. Jahan, P., Cheruvu, R., Tippisetty, S., Komaravalli, P.L., Valluri, V., and Ishaq, M. (2013). Association of FOXP3 (rs3761548) promoter polymorphism with nondermatomal vitiligo: a study from India. J. Am. Acad. Dermatol. PII: S0190-9622(13)00184-189.
13. Kemp, E.H., Gawkrodger, D.J., MacNeil, S., Watson, P.F., and Weetman, A.P. (1997). Detection of tyrosinase autoantibodies in patients with vitiligo using 35Slabeled recombinant human tyrosinase in a radioimmunoassay. J. Invest. Dermatol. 109, 69-73.
14. Klarquist, J., Denman, C.J., Hernandez, C., Wainwright, D.A., Strickland, F.M., Overbeck, A., Mehrotra, S., Nishimura, M.I., and Le Poole, I.C. (2010). Reduced skin homing by functional Treg in vitiligo. Pigment Cell Melanoma Res. 23, 276-286.
15. Laddha, N.C., Dwivedi, M., and Begum, R. (2012). Increased Tumor Necrosis Factor (TNF)-α and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo. PLoS ONE 7, e52298.
16. Lang, K., Caroli, C., Muhm, A., Wernet, D., Moris, A., Schittek, B., Knauss-Scherwitz, E., Stevanovic, S., Rammensee, H.G., and Garbe, C. (2001). HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1. J. Invest. Dermatol. 116, 891-897.
17. Le Poole, I., and Luiten, R. (2008). Autoimmune etiology of generalized vitiligo. Curr. Dir. Autoimmun. 10, 227-243.
18. Le Poole, I., Wañkowicz-Kaliñska, A., van den Wijngaard, R., Nickoloff, B., and Das, P. (2004). Autoimmune aspects of depigmentation in vitiligo. J. Invest. Dermatol. Symp. Proc. 9, 68-72.
19. Levings, M., Sangregorio, R., and Roncarolo, M. (2001). Human CD25(+) CD4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193, 1295-1302.
20. Lili, Y., Yi, W., Ji, Y., Yue, S., Weimin, S., and Ming, L. (2012). Global activation of CD8 + cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo. PLoS ONE 7, e37513.
21. + regulatory T-cells in autoimmune liver disease. J. Hepatol. 41, 31-37.
22. Nigam, P.K., Patra, P.K., Khodiar, P.K., and Gual, J. (2011). A study of blood CD3 + CD4 + and CD8 + T cell levels and CD4 + :CD+ ratio in vitiligo patients. Indian J. Dermatol. Venerol. Leprol. 77, 111.
23. Pichler, R., Sfetsos, K., Badics, B., Gutenbrunner, S., Berg, J., and Auböck, J. (2009). Lymphocyte imbalance in vitiligo patients indicated by elevated CD4 + /CD8 + T-cell ratio. Wien. Med. Wochenschr. 159, 337-341.
24. Sakaguchi, S. (2004). Naturally arising CD4(+) regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22, 531-562.
25. Singh, S., Singh, U., and Pandey, S.S. (2012a). Serum concentration of IL-6, IL-2, TNF-α, and IFNγ in vitiligo patients. Indian J. Dermatol. 57, 12-14.
26. Singh, A., Sharma, P., Kar, H.K. et al. (2012b). HLA alleles and amino acid signatures of the peptide binding pockets of HLA molecules in vitiligo. J. Invest. Dermatol. 132, 124-134.
27. Wankowicz-Kalinska, A., van den Wijngaard, R.M., Tigges, B.J., Westerhof, W., Ogg, G.S., Cerundolo, V., Storkus, W.J., and Das, P.K. (2003). Immunopolarization of CD4 + and CD8 + T cells to type-1-like is associated with melanocyte loss in human vitiligo. Lab. Invest. 83, 683-695.
28. Wu, J., Zhou, M., Wan, Y., and Xu, A. (2012). CD8 + T cells from vitiligo perilesional margins induce autologous melanocyte apoptosis. Mol. Med. Report 7, 237-241.
29. Yagi, H., Nomura, T., Nakamura, K. et al. (2004). Crucial role of FOXP3 in the development and function of human CD25 + CD4 + regulatory T-cells. Int. Immunol. 16, 1643-1656.
30. Zhang, P., Côté, A.L., de Vries, V.C., Usherwood, E.J., and Turk, M.J. (2007). Induction of postsurgical tumor immunity and T-cell memory by a poorly immunogenic tumor. Cancer Res. 1, 6468-6476.
31. Zhou, L., Li, K., Shi, Y.L. et al. (2012). Systemic analyses of immunophenotypes of peripheral T cells in non-segmental vitiligo: implication of defective natural killer T cells. Pigment Cell Melanoma Res. 25, 602-611.